AUCKLAND, New Zealand, July 29 (Bernama) -- The a2 Milk Company today announced new clinical and preclinical research presented at NUTRITION 2026, the annual meeting of the American Society for Nutrition. The studies examined infant growth and safety, protein utilization and gastrointestinal biomarkers, and the respective roles of lactose and beta-casein in digestive tolerance.
The presentations included two studies from The a2 Milk Company and company-funded research conducted by Purdue University and Nova Southeastern University investigators. They add to the company’s research program focused on naturally occurring beta-casein variants and their potential effects on digestion and health.